Smith Nephew Plc Stock Performance
| SNNUF Stock | USD 12.25 0.07 0.57% |
The entity has a beta of -1.46, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Smith Nephew are expected to decrease by larger amounts. On the other hand, during market turmoil, Smith Nephew is expected to outperform it. At this point, Smith Nephew plc has a negative expected return of -0.27%. Please make sure to validate Smith Nephew's information ratio, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Smith Nephew plc performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Smith Nephew plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 1.8 B | |
| Total Cashflows From Investing Activities | -691 M |
Smith |
Smith Nephew Relative Risk vs. Return Landscape
If you would invest 1,500 in Smith Nephew plc on August 26, 2024 and sell it today you would lose (275.00) from holding Smith Nephew plc or give up 18.33% of portfolio value over 90 days. Smith Nephew plc is currently producing negative expected returns and takes up 2.985% volatility of returns over 90 trading days. Put another way, 26% of traded pink sheets are less volatile than Smith, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Smith Nephew Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Smith Nephew's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Smith Nephew plc, and traders can use it to determine the average amount a Smith Nephew's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0903
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | SNNUF |
Estimated Market Risk
| 2.99 actual daily | 26 74% of assets are more volatile |
Expected Return
| -0.27 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Smith Nephew is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Smith Nephew by adding Smith Nephew to a well-diversified portfolio.
Smith Nephew Fundamentals Growth
Smith Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Smith Nephew, and Smith Nephew fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Smith Pink Sheet performance.
| Return On Equity | 0.0925 | |||
| Return On Asset | 0.0425 | |||
| Profit Margin | 0.1 % | |||
| Operating Margin | 0.14 % | |||
| Current Valuation | 14.08 B | |||
| Shares Outstanding | 873.35 M | |||
| Price To Earning | 23.41 X | |||
| Price To Book | 2.12 X | |||
| Price To Sales | 2.26 X | |||
| Revenue | 5.21 B | |||
| EBITDA | 1.25 B | |||
| Cash And Equivalents | 516 M | |||
| Cash Per Share | 0.59 X | |||
| Total Debt | 2.71 B | |||
| Debt To Equity | 0.54 % | |||
| Book Value Per Share | 6.16 X | |||
| Cash Flow From Operations | 877 M | |||
| Earnings Per Share | 0.57 X | |||
| Total Asset | 10.92 B | |||
| Retained Earnings | 3.72 B | |||
| Current Asset | 2.55 B | |||
| Current Liabilities | 1.34 B | |||
About Smith Nephew Performance
By analyzing Smith Nephew's fundamental ratios, stakeholders can gain valuable insights into Smith Nephew's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Smith Nephew has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Smith Nephew has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 18000 people.Things to note about Smith Nephew plc performance evaluation
Checking the ongoing alerts about Smith Nephew for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Smith Nephew plc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Smith Nephew plc generated a negative expected return over the last 90 days |
- Analyzing Smith Nephew's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Smith Nephew's stock is overvalued or undervalued compared to its peers.
- Examining Smith Nephew's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Smith Nephew's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Smith Nephew's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Smith Nephew's pink sheet. These opinions can provide insight into Smith Nephew's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Smith Pink Sheet analysis
When running Smith Nephew's price analysis, check to measure Smith Nephew's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Smith Nephew is operating at the current time. Most of Smith Nephew's value examination focuses on studying past and present price action to predict the probability of Smith Nephew's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Smith Nephew's price. Additionally, you may evaluate how the addition of Smith Nephew to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |